舒肝解郁胶囊治疗以头晕为主诉的无症状性脑梗死患者的焦虑抑郁状态的疗效
Studies of Trace Elements and Health(2019)
Abstract
目的:探讨以头晕为主诉的无症状性脑梗死(SBI)患者的焦虑抑郁状态经舒肝解郁胶囊治疗后的临床疗效.方法:采用汉密尔顿焦虑量表(HAMA)和汉密尔顿抑郁量表(HAMD)对72例以头晕为主诉的SBI患者进行心理状态的评定,并按疗程给予舒肝解郁胶囊治疗6周后,以治疗前后HAMA、HAMD评分来评定疗效.结果:通过HAMA和HAMD评定,72例以头晕为主诉的SBI患者经疏肝解郁胶囊治疗后与治疗前比较差异具有显著的统计学意义(P<0.01).结论:舒肝解郁胶囊治疗以头晕为主诉的无症状性脑梗死患者的焦虑抑郁状态的疗效可靠,可以进行推广.
MoreAI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined